| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |